Literature DB >> 19165748

Effects of yokukansan, a traditional Japanese medicine, on aggressiveness induced by intracerebroventricular injection of amyloid beta protein into mice.

Kyoji Sekiguchi1, Takuji Yamaguchi, Masahiro Tabuchi, Yasushi Ikarashi, Yoshio Kase.   

Abstract

The effects of yokukansan, a traditional Japanese medicine, on aggressiveness and motor activities were examined in mice after injection of amyloid beta protein (Abeta) into the lateral ventricle of the brain. The results were compared with those of conventional (haloperidol) and atypical (risperidone) antipsychotic medicines. A significant increase in aggressiveness was observed on day 7 after injection of Abeta, and it lasted until day 28. A single oral administration of yokukansan (1.0 g/kg) did not ameliorate the aggressiveness observed on day 7. However, a tendency toward amelioration of the aggressiveness was observed after the administration of yokukansan (0.5 and 1.0 g/kg) for 1 week (days 7-14). The 3 week administration (days 7-28) of yokukansan significantly ameliorated the aggressiveness in a dose-dependent manner without inhibition of motor activity. In contrast, a single administration of intraperitoneal haloperidol (0.03-0.1 mg/kg) or oral risperidone (0.1-0.3 mg/kg) on day 28 significantly reduced aggressiveness in a dose-dependent manner. However, motor activities were significantly suppressed. These results suggest yokukansan reduces aggressiveness without suppressing physical activity. Copyright 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19165748     DOI: 10.1002/ptr.2777

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  7 in total

1.  Yokukansan inhibits neuronal death during ER stress by regulating the unfolded protein response.

Authors:  Toru Hiratsuka; Shinsuke Matsuzaki; Shingo Miyata; Mitsuhiro Kinoshita; Kazuaki Kakehi; Shinji Nishida; Taiichi Katayama; Masaya Tohyama
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

2.  Traditional used Plants against Cognitive Decline and Alzheimer Disease.

Authors:  Gunter Peter Eckert
Journal:  Front Pharmacol       Date:  2010-12-08       Impact factor: 5.810

Review 3.  Multiple Psychopharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan, and the Brain Regions it Affects.

Authors:  Kazushige Mizoguchi; Yasushi Ikarashi
Journal:  Front Pharmacol       Date:  2017-03-21       Impact factor: 5.810

4.  The effect of PN-1, a Traditional Chinese Prescription, on the Learning and Memory in a Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Zhi-Gang Yao; Ling Zhang; Liang Liang; Yu Liu; Ya-Jun Yang; Lan Huang; Hua Zhu; Chun-Mei Ma; Chuan Qin
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-17       Impact factor: 2.629

Review 5.  Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions.

Authors:  Hideki Okamoto; Masaomi Iyo; Keigo Ueda; Cheolsun Han; Yoshiro Hirasaki; Takao Namiki
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-12       Impact factor: 2.570

Review 6.  Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells.

Authors:  Kazushige Mizoguchi; Yasushi Ikarashi
Journal:  Front Pharmacol       Date:  2017-09-20       Impact factor: 5.810

7.  Basic Study of Drug-Drug Interaction between Memantine and the Traditional Japanese Kampo Medicine Yokukansan.

Authors:  Takashi Matsumoto; Kyoji Sekiguchi; Zenji Kawakami; Junko Watanabe; Kazushige Mizoguchi; Yasushi Ikarashi; Masahiro Yamamoto
Journal:  Molecules       Date:  2018-12-29       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.